Market Update: Agilent Technologies Inc (NYSE:A) – Agilent Technologies Launches New Solutions for Pharma, Biopharma, Metabolomics and Environmental Researchers Across Mass Spec Portfolio
June 06, 2016 at 11:00 AM EDT
window.location="http://v1.townbob.com/f3530686-674c-4550-9a3b-a5fee0fe1c69"; [Business Wire] – Agilent Technologies Inc. today introduced a wide range of systems, software and technologies designed to improve both the speed and accuracy of mass spectrometry. Read more on this. Agilent Technologies, Inc. (A) , valued at $15.04B, began trading this morning at $45.72. Looking at the equity, the company’s one day range is $45.69 to $46.01 and has traded between $33.12 and $46.15 over the past 12 months. A shares are currently priced at 24.06x this year’s forecasted earnings, which makes them relatively expensive compared to the industry’s 7.60x earnings multiple for the same period. The company pays shareholders $0.46 per share in dividend income per year, for a current yield of 1.01%. Consensus earnings for the current quarter by the 14 sell-side analysts covering the stock is an estimate of $0.47 per share, which would be $0.03 better than the year-ago quarter and a $0.01 sequential decrease. The full-year EPS estimate is $1.91, which would be a $0.17 better than last year. The quarterly earnings estimate is predicated on a consensus revenue forecast of $1.04 Billion. If reported, that would be a 2.97% increase over the year-ago quarter. In terms of ratings, Deutsche Bank Initiated A at Hold (Jan 7, 2016). Previously, UBS Initiated A at to Neutral. The average price target for A shares by the analysts covering the stock is $49.00, which is 7.17% above where the stock opened this morning. See more in (NYSE:A) Similar Articles: Company Update: Agilent Technologies Inc (NYSE:A) – Agilent Technologies Introduces InfinityLab Liquid Chromatography Instruments, Columns and Supplies Market Update: Agilent Technologies Inc (NYSE:A) – Dako, an Agilent Technologies Company, Announces Expanded FDA Approval of Complementary Diagnostic Test to Include Melanoma Market Update: Agilent Technologies Inc (NYSE:A) – Agilent Technologies Names Michael Tang Senior Vice President, General Counsel and Secretary